Battling A $500 BILLION Annual Opioid Crisis
Focused on developing medical products and regimens that address addiction
Nirvana Life Sciences Inc. Links
Novel Formulations
The company has purchased a portfolio of Intellectual Property from researchers with vast experience in the psychedelics space.
Posted by:
AGORACOM-NR
on
Sep 13, 2022 12:52PM
Pre-Clinical Research
Nirvana is planning on growing several genera and species of fungi (including rare and hybrid varieties) with a high standard of quality and batch consistency.
Posted by:
AGORACOM-NR
on
Sep 13, 2022 12:51PM
Nirvana Life Sciences Interview with Robert August
Knox Henderson, editor of the Financial Press interviews Robert August, lead chemist at Nirvana Life Sciences (NIRV:CSE)
Posted by:
AGORACOM-NR
on
Sep 13, 2022 12:51PM